Alita J van der Sluijs-Gelling
Overview
Explore the profile of Alita J van der Sluijs-Gelling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
244
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paardekooper L, Fillie-Grijpma Y, van der Sluijs-Gelling A, Zlei M, van Doorn R, Vermeer M, et al.
Clin Immunol
. 2023 Nov;
257:109817.
PMID: 37925120
A subset of autoimmune diseases is characterized by predominant pathogenic IgG4 autoantibodies (IgG4-AID). Why IgG4 predominates in these disorders is unknown. We hypothesized that dysregulated B cell maturation or aberrant...
2.
van der Pan K, de Bruin-Versteeg S, Damasceno D, Hernandez-Delgado A, van der Sluijs-Gelling A, van den Bossche W, et al.
Front Immunol
. 2022 Oct;
13:935879.
PMID: 36189252
Innate myeloid cell (IMC) populations form an essential part of innate immunity. Flow cytometric (FCM) monitoring of IMCs in peripheral blood (PB) has great clinical potential for disease monitoring due...
3.
Bras A, Matarraz S, Nierkens S, Fernandez P, Philippe J, Aanei C, et al.
Cancers (Basel)
. 2022 Apr;
14(8).
PMID: 35454917
Flowcytometric analysis allows for detailed identification and characterization of large numbers of cells in blood, bone marrow, and other body fluids and tissue samples and therefore contributes to the diagnostics...
4.
Najidh S, Tensen C, van der Sluijs-Gelling A, Teodosio C, Cats D, Mei H, et al.
Blood
. 2021 Jul;
138(24):2539-2554.
PMID: 34314480
Sézary syndrome (SS) is an aggressive leukemic form of cutaneous T-cell lymphoma with neoplastic CD4+ T cells present in skin, lymph nodes, and blood. Despite advances in therapy, prognosis remains...
5.
de Haas V, Pieters R, van der Sluijs-Gelling A, Zwaan C, de Groot-Kruseman H, Sonneveld E, et al.
Leukemia
. 2020 Aug;
35(6):1773-1776.
PMID: 32855440
No abstract available.
6.
Theunissen P, Mejstrikova E, Sedek L, van der Sluijs-Gelling A, Gaipa G, Bartels M, et al.
Blood
. 2016 Dec;
129(3):347-357.
PMID: 27903527
A fully-standardized EuroFlow 8-color antibody panel and laboratory procedure was stepwise designed to measure minimal residual disease (MRD) in B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) patients with a sensitivity...
7.
Kalina T, Flores-Montero J, Lecrevisse Q, Pedreira C, van der Velden V, Novakova M, et al.
Cytometry A
. 2014 Oct;
87(2):145-56.
PMID: 25345353
Flow cytometric immunophenotyping has become essential for accurate diagnosis, classification, and disease monitoring in hemato-oncology. The EuroFlow Consortium has established a fully standardized "all-in-one" pipeline consisting of standardized instrument settings,...
8.
Bras A, van den Heuvel-Eibrink M, van der Sluijs-Gelling A, Coenen E, Wind H, Zwaan C, et al.
Br J Haematol
. 2013 Apr;
161(6):861-4.
PMID: 23577982
B-cell precursors (BCP) regeneration in bone marrow (BM) after induction chemotherapy is prognostic for good treatment response in adult acute myeloid leukaemia (AML). We detected BCP regeneration in 81% of...